Supplementary Figure S1 from A First-in-Human Phase 1 Study of a Tumor-Directed RNA-Interference Drug Against HIF2α in Patients with Advanced Clear Cell Renal Cell Carcinoma
crossref(2024)
Abstract
Figure S1. AROHIF21001 Study Design
MoreTranslated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined